LOVENOX® helps reduce the risk of developing
deep vein thrombosis (DVT blood clots)

Not all medications that thin blood are appropriate for DVT blood clot intervention. Patients taking daily low-dose aspirin alone are not protected from developing a DVT blood clot. This regimen may help reduce the risk of blood clots that develop in the arteries. A DVT blood clot is a blood clot that develops in the veins and may require specific medication.

A DVT blood clot on its own is not life-threatening. However, if a blood clot breaks free from the wall of the vein and travels up to the lungs, it can block the pulmonary artery or one of its branches, causing a pulmonary embolism (PE), which can be fatal. With LOVENOX®, the blood€™s normal clotting process is altered, so clots can€™t form as easily.

Your doctor may prescribe LOVENOX® if you are hospitalized with certain medical conditions or surgeries, or have additional risk factors for developing DVT blood clots. Usual treatment with LOVENOX® varies depending on your specific medical or surgical condition. LOVENOX® is usually administered in the hospital and may be continued at home if recommended by your doctor. Follow your doctor's instructions on how long to take LOVENOX® and at what dosing schedule.

Important Safety Information

Certain procedures, called "epidural/spinal anesthesia" and "spinal puncture," may be used as a normal part of hospitalization. Patients requiring these procedures while being treated with LOVENOX® or other low-molecular-weight heparins are at risk of developing a blood clot in or around the spine. This condition may result in long-term or permanent paralysis.

LOVENOX® is not the same as "unfractionated heparin" or other drugs called "low-molecular-weight heparins." Therefore, these drugs cannot be used interchangeably with LOVENOX®.

LOVENOX® can alter the blood€™s ability to clot. Patients treated with LOVENOX®, who also have conditions affecting the clotting system, must be carefully monitored by their physician. Adjusting the dose of LOVENOX® may be necessary for patients who have certain forms of kidney disease. All patients receiving LOVENOX®, as well as other anticoagulants, should be carefully monitored for bleeding by their physician. Bleeding can occur at any site with LOVENOX® use.

Platelet drops, known as "thrombocytopenia," can occur with LOVENOX® use. Cases of a related condition called "heparin-induced thrombocytopenia" have been observed in clinical practice. If you have had this condition, you must notify your healthcare professional. Your physician may perform blood tests to monitor for the occurrence of any drop in platelet count.

The use of LOVENOX® has not been adequately studied in pregnant women with artificial (mechanical) heart valves.

LOVENOX® should not be used in patients with an allergy or sensitivity reaction to the active ingredient called enoxaparin sodium, heparin, or pork products, and in patients with active major bleeding.

Common side effects include mild local reactions or irritation at the site of injection, pain, bruising, and redness of skin.

For specific questions about your health, you should always consult your physician or a qualified healthcare professional who is responsible for your care.

Alternative Brand Name: Clexane 40mg